Weimar I S, Weijer K, van den Berk P C, Muller E J, Miranda N, Bakker A Q, Heemskerk M H, Hekman A, de Gast G C, Gerritsen W R
Division of Immunology, Netherlands Cancer Institute, Amsterdam.
Br J Cancer. 1999 Sep;81(1):43-53. doi: 10.1038/sj.bjc.6690649.
The MET protooncogene, c-MET, encodes a cell surface tyrosine kinase receptor. The ligand for c-MET is hepatocyte growth factor (HGF), also known as scatter factor (SF), which is known to affect proliferation and motility of primarily epithelial cells. Recently, HGF/SF was also shown to affect haemopoiesis. Studies with epithelial and transfected NIH3T3 cells indicated that the HGF/SF-c-MET interaction promotes invasion in vitro and in vivo. We previously demonstrated that HGF/SF induces adhesion of c-MET-positive B-lymphoma cells to extracellular matrix molecules, and promoted migration and invasion in in vitro assays. Here, the effect of HGF/SF on tumorigenicity of c-MET-positive and c-MET-negative human B-lymphoma cell lines was studied in C.B-17 scid/scid (severe combined immune deficient) mice. Intravenously (i.v.) injected c-MET-positive (BJAB) as well as c-MET-negative (Daudi and Ramos cells) B-lymphoma cells formed tumours in SCID mice. The B-lymphoma cells invaded different organs, such as liver, kidney, lymph nodes, lung, gonads and the central nervous system. We assessed the effect of human HGF/SF on the dissemination of the B-lymphoma cells and found that administration of 5 microg HGF/SF to mice, injected (i.v.) with c-MET-positive lymphoma cells, significantly (P = 0.018) increased the number of metastases in lung, liver and lymph nodes. In addition, HGF/SF did not significantly influence dissemination of c-MET-negative lymphoma cells (P = 0.350 with Daudi cells and P= 0.353 with Ramos cells). Thus the effect of administration of HGF/SF on invasion of lymphoma cells is not an indirect one, e.g. via an effect on endothelial cells. Finally, we investigated the effect of HGF/SF on dissemination of c-MET-transduced Ramos cells. In response to HGF/SF, c-MET-transduced Ramos cells showed an increased migration through Matrigel in Boyden chambers compared to wild-type and control-transduced Ramos cells. The dissemination pattern of c-MET-transduced cells did not differ from control cells in in vivo experiments using SCID mice. Also no effect of HGF/SF administration could be documented, in contrast to the in vitro experiments. From our experiments can be concluded that the HGF/SF-c-MET interaction only plays a minor role in the dissemination of human B-lymphoma cells.
原癌基因MET,即c-MET,编码一种细胞表面酪氨酸激酶受体。c-MET的配体是肝细胞生长因子(HGF),也称为分散因子(SF),已知其主要影响上皮细胞的增殖和运动。最近,HGF/SF也被证明会影响造血作用。对上皮细胞和转染的NIH3T3细胞的研究表明,HGF/SF-c-MET相互作用在体外和体内均能促进侵袭。我们之前证明,HGF/SF可诱导c-MET阳性B淋巴瘤细胞与细胞外基质分子黏附,并在体外实验中促进其迁移和侵袭。在此,我们在C.B-17 scid/scid(严重联合免疫缺陷)小鼠中研究了HGF/SF对c-MET阳性和c-MET阴性人B淋巴瘤细胞系致瘤性的影响。静脉注射(i.v.)的c-MET阳性(BJAB)以及c-MET阴性(Daudi和Ramos细胞)B淋巴瘤细胞在SCID小鼠中形成肿瘤。B淋巴瘤细胞侵袭了不同器官,如肝脏、肾脏、淋巴结、肺、性腺和中枢神经系统。我们评估了人HGF/SF对B淋巴瘤细胞播散的影响,发现给静脉注射(i.v.)c-MET阳性淋巴瘤细胞的小鼠注射5μg HGF/SF后,肺、肝脏和淋巴结中的转移灶数量显著增加(P = 0.018)。此外,HGF/SF对c-MET阴性淋巴瘤细胞的播散没有显著影响(Daudi细胞P = 0.350,Ramos细胞P = 0.353)。因此,给予HGF/SF对淋巴瘤细胞侵袭的影响不是间接的,例如不是通过对内皮细胞的作用。最后,我们研究了HGF/SF对c-MET转导的Ramos细胞播散的影响。与野生型和对照转导的Ramos细胞相比,在响应HGF/SF时,c-MET转导的Ramos细胞在Boyden小室中通过基质胶的迁移增加。在使用SCID小鼠的体内实验中 c-MET转导细胞的播散模式与对照细胞没有差异。与体外实验相反,也未记录到给予HGF/SF的效果。从我们的实验可以得出结论,HGF/SF-c-MET相互作用在人B淋巴瘤细胞的播散中仅起次要作用。